Matthew Meriggioli to Adult
This is a "connection" page, showing publications Matthew Meriggioli has written about Adult.
Connection Strength
0.337
-
Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis. Clin Immunol. 2012 Dec; 145(3):209-23.
Score: 0.043
-
Mycophenolate mofetil in dermatomyositis: is it safe? Neurology. 2006 Apr 25; 66(8):1245-7.
Score: 0.028
-
Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability. Neurology. 2003 Nov 25; 61(10):1438-40.
Score: 0.023
-
Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Ann N Y Acad Sci. 2003 Sep; 998:494-9.
Score: 0.023
-
Single fiber EMG as an outcome measure in myasthenia gravis: results from a double-blind, placebo-controlled trial. J Clin Neurophysiol. 2003 Sep-Oct; 20(5):382-5.
Score: 0.023
-
Clinical immunopharmacology of autoimmune neuropathies and myopathies. Clin Neuropharmacol. 2002 May-Jun; 25(3):174-81.
Score: 0.021
-
Myasthenia gravis. Clin Neuropharmacol. 2000 Nov-Dec; 23(6):291-5.
Score: 0.019
-
Treatment of myasthenia gravis with mycophenolate mofetil: a case report. Muscle Nerve. 2000 Aug; 23(8):1287-9.
Score: 0.019
-
Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve. 2000 Mar; 23(3):433-5.
Score: 0.018
-
Distinguishing clinical and electrodiagnostic features of X-linked bulbospinal neuronopathy. Muscle Nerve. 1999 Dec; 22(12):1693-7.
Score: 0.018
-
Complex repetitive discharges: cause or effect of neurogenic muscle hypertrophy? Muscle Nerve. 1999 Nov; 22(11):1603-6.
Score: 0.018
-
Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy. Neurol Neuroimmunol Neuroinflamm. 2019 01; 6(1):e523.
Score: 0.017
-
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018 12; 17(12):1043-1052.
Score: 0.016
-
Novel and recurrent EMD mutations in patients with Emery-Dreifuss muscular dystrophy, identify exon 2 as a mutation hot spot. J Hum Genet. 2011 Aug; 56(8):589-94.
Score: 0.010
-
Hashimoto encephalopathy with fulminant myocarditis. Pathol Res Pract. 2010 Oct 15; 206(10):720-2.
Score: 0.009
-
Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. Neuromuscul Disord. 2006 Feb; 16(2):137-43.
Score: 0.007
-
Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. 2004 Dec 28; 63(12):2390-2.
Score: 0.006
-
Prominent inflammatory changes on muscle biopsy in patients with Miyoshi myopathy. Neuromuscul Disord. 1999 Oct; 9(6-7):417-20.
Score: 0.004
-
Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin. Minerva Med. 1998 Nov-Dec; 89(11-12):405-9.
Score: 0.004
-
Circulating levels of IGF-I in patients with chronic uremia on conservative dietary treatment. Ren Fail. 1998 Mar; 20(2):357-60.
Score: 0.004
-
Coagulation activation in extracorporeal hemodialysis. Int J Artif Organs. 1997 Mar; 20(3):163-5.
Score: 0.004
-
[Coagulation in hemodialysis]. Minerva Med. 1996 Nov; 87(11):509-14.
Score: 0.004